Bronchitis

The FDA has granted clearance to TytoCare’s AI-powered Tyto Insights for Lung Sounds to detect rhonchi, marking the third lung sound alongside wheeze and crackles to receive the designation, according to a press release.

The likelihood for upper respiratory tract infections and wheeze in children was impacted by when the child was born in relation to the COVID-19 pandemic, according to findings published in The Journal of Allergy and Clinical Immunology.

An antibiotic stewardship intervention at urgent care centers was associated with lower rates of inappropriate prescribing for bronchitis and viral upper respiratory infections, although active clinician engagement is necessary, researchers found.

Around 20% to 25% of individuals with rapidly declining FEV1/FVC trajectories experienced wheezing and usual phlegm/bronchitis as adolescents/young adults, according to results published in The Lancet Respiratory Medicine.

In 2022, chronic lower respiratory disease was the sixth highest cause of death in the U.S., according to results published in National Vital Statistics Reports.

Among adults with COPD and bronchitis, receiving 600 mg of tozorakimab every 4 weeks may lead to FEV1 improvement, according to a poster presented at the European Respiratory Society International Congress.

Four variables, including chronic bronchitis and high symptom burden, heightened the rate of exacerbations among patients with COPD and no recent exacerbations, according to results published in Annals of the American Thoracic Society.

SAN DIEGO — Among patients with COPD and heightened eosinophil levels, mepolizumab lowered annualized exacerbation rates, according to a presentation at the American Thoracic Society International Conference.

Individuals exposed to nitrogen dioxide and particulate matter less than 10 µm as a child faced elevated odds for bronchitic symptoms as an adult, according to results published in American Journal of Respiratory and Critical Care Medicine.